Sanjay R. Kedhar

Director, Ocular Immunology and Uveitis Service, Ophthalmology
School of Medicine

Health Sciences Associate Clinical Professor, Ophthalmology
School of Medicine

B.A., University of California, Berkeley, CA, 1995, Molecular Cell Biology/Immunology


M.D., New York Medical College School of Medicine, Valhalla, NY, 1999

Phone: (949) 824-3134
Email: skedhar@uci.edu

University of California, Irvine
Department of Ophthalmology
850 Health Sciences Rd.
Mail Code: 4375
Irvine, CA 92697

picture of Sanjay R. Kedhar

Research
Interests
Uveitis Research and Treatment, Ocular Immunology, Cornea and External Disease, Infantile and Pediatric Corneal Transplantation
   
Academic
Distinctions
Diplomate, American Board of Ophthalmology
Diplomate, National Board of Medical Examiners
Achievement Award, American Academy of Ophthalmology
Resident Teaching Award, The New York Eye & Ear Infirmary, NY - 2009
Resident Teaching Award, The Wilmer Eye Institute/Greater Baltimore Medical Center, MD - 2007
Special Resident Teaching Award, The Wilmer Eye Institute, Johns Hopkins University, MD - 2005
Walter J. Stark Research Award, Wilmer Eye Institute Research Award, Johns Hopkins University, MD - 2003
William H. and Judith Turner Award, Most Outstanding Resident The New York Eye & Ear Infirmary, NY - 2003
First Place, Dean’s Annual Research Forum, New York Medical College, NY - 1997
American Cancer Society Research Fellowship - 1994
   
Publications SELECTED PEER-REVIEWED PUBLICATIONS
   
  52. Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. doi: 10.1167/iovs.15-18626.

51. Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis JL, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Am J Ophthalmol. 2016 Apr;164:29-36. doi: 10.1016/j.ajo.2015.12.028. Epub 2015 Dec 31.

50. Scripsema NK, Sharifi E, Samson CM, Kedhar S, Rosen RB. Chikungunya-Associated Uveitis and Exudative Retinal Detachment: A Case Report. Retin Cases Brief Rep. 2015 Fall;9(4):352-6.

49. Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9.

48. Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.
   
  47. Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study. Ophthalmology. 2015 Oct;122(10):1976-86.

46. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 2015 Oct;122(10):1967-75.

45. Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015 Sep 1;85(9):799-805.

44. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9.

43. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8

42. Lou SM, Larkin KL, Winthrop K, Rosenbaum JT; Uveitis Specialists Study Group. Lack of Consensus in the diagnosis and treatment of ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm. 2015 Feb;23(1):25-31.
   
  36. Hsieh J, Honda AF, Suárez-Fariñas M, Samson CM, Kedhar S, Mauro J, Francis J, Badamo J, Diaz VA, Kempen JH, Latkany PA. Fundus image diagnostic agreement in uveitis utilizing free and open source software. Can J Ophthalmol. 2013 Aug;48(4):227-34.
   
  34. Feng X, Kedhar S, Bhoomibunchoo C. Retinal blood flow velocity in patients with active uveitis using the retinal function imager. Chin Med J (Engl). 2013;126(10):1944-7.
   
  30. Kedhar SR. Annual Review: Research in Uveitis and Ocular Inflammation, 2011-2012. Asia-Pacific Journal of Ophthalmology. 2013 May/June;2(3):187-198.
   
  BOOK CHAPTERS

3. Kedhar SR, Kresch Z, Daniel E. Chapter 56: Mycobacterial Diseases of the Eye.
In: Tasman W, Jaeger EA, eds. Duane’s Ophthalmology 2013. Philadelphia: Lippincott Williams & Wilkins. 2013.

2. Dunn JP, Kedhar SR. Ankylosing spondylitis and Reiter’s disease. In: Roy FH, Fraunfelder FT, Fraunfelder, FW, Tindall RC, eds. Current Ocular Therapy, 6th Ed. Philadelphia: WB Saunders Company. 2007.

1. Kedhar S, Schein OD. Use of pericardium and sclera in corneal-scleral melts. In: John Thomas, ed. Surgical Techniques in Anterior and Posterior Lamellar Corneal Surgery. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd. 2006.
   
Professional
Societies
American Academy of Ophthalmology
New York Ophthalmological Society
Association for Research in Vision and Ophthalmology (ARVO)
American Uveitis Society
American Society of Cataract and Refractive Surgery
The Cornea Society
   
Other Experience Internship
St. Vincent's Hospital and Medical Center, New York, NY —2000

Residency
The New York Eye & Ear Infirmary, Department of Ophthalmology, New York, NY —2003

Assistant (Clinical Fellowship) - Cornea, Anterior Segment Disease
The Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD —2004

Assistant (Clinical Fellowship) - Ocular Immunology/Uveitis
The Wilmer Eye Institute, Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD —2005

   
Link to this profile http://www.faculty.uci.edu/profile.cfm?faculty_id=6217
   
Last updated 03/28/2017